XML 16 R3.htm IDEA: XBRL DOCUMENT v3.22.4
CONSOLIDATED STATEMENT OF OPERATIONS - USD ($)
shares in Millions, $ in Millions
 12 Months Ended
Oct. 31, 2022
Oct. 31, 2021
Oct. 31, 2020
Net revenue:      
Net revenue $ 6,848 $ 6,319 $ 5,339
Costs and expenses:      
Cost of revenue 3,126 2,912 2,502
Research and development 467 441 495
Selling, general and administrative 1,637 1,619 1,496
Total costs and expenses 5,230 4,972 4,493
Income from operations 1,618 1,347 846
Interest income 9 2 8
Interest expense (84) (81) (78)
Other income (expense), net (39) 92 66
Income before taxes 1,504 1,360 842
Provision for income taxes 250 150 123
Net Income $ 1,254 $ 1,210 $ 719
Net income per share:      
Net income per share - basic $ 4.19 $ 3.98 $ 2.33
Net income per share - diluted $ 4.18 $ 3.94 $ 2.30
Weighted Averge Shares Used In Computing Net Income Per Share      
Basic (in shares) 299 304 309
Diluted (in shares) 300 307 312
Products      
Net revenue:      
Net revenue $ 5,187 $ 4,756 $ 3,993
Costs and expenses:      
Cost of revenue 2,242 2,078 1,796
Services and Other      
Net revenue:      
Net revenue 1,661 1,563 1,346
Costs and expenses:      
Cost of revenue $ 884 $ 834 $ 706